Lv7
4385 积分 2020-09-11 加入
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering
2个月前
已完结
[Evaluation on the effect of comprehensive intervention combined with clinical preventive services and lifestyle adjustment among high-risk populations of cardiovascular disease in Tongxiang City]
2个月前
已完结
Lipoprotein(a): Knowns, unknowns and uncertainties
3个月前
已完结
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk
3个月前
已完结
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
4个月前
已完结
LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics
5个月前
已完结
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
5个月前
已完结
Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis
5个月前
已完结
Lipoprotein(a) and cardiovascular disease
5个月前
已完结
FTO knockout in adipose tissue effectively alleviates hepatic steatosis partially via increasing the secretion of adipocyte-derived IL-6
5个月前
已完结
皖公网安备34019202002308
